Pharma Marketing Network

MAY 18, 2025

Can a flashy website really move the needle for an oncology brand? Is social media too risky for pharma compliance? These questions reflect some of the biggest myths in digital marketing in pharma , an area that continues to evolve at warp speed yet remains tethered by legacy thinking. Many marketers in the pharmaceutical industry struggle to balance innovation with regulation, often falling into traps set by outdated beliefs.

FDA 52

FDA Communication 52

Drug Topics

MAY 18, 2025

Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.

492

492

The FDA Law Blog

MAY 19, 2025

By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.

Controlled Substances 65

Controlled Substances Dosage Insurance 65

Pharmacy Times

MAY 18, 2025

Naxitamab-gqgk has been added as a Category 2A recommendation in the updated National Comprehensive Cancer Network (NCCN) guidelines for high-risk neuroblastoma, reflecting growing consensus on its role in treating relapsed or refractory disease.

65

65

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharma Marketing Network

MAY 18, 2025

Imagine youre trying to reach a specialist in a bustling hospitalyour message is a whisper in a sea of noise. How do you get through? In the complex world of healthcare, pharmaceutical marketing strategies must evolve to genuinely connect with healthcare professionals (HCPs). No longer effective are blanket tactics or generic messaging. Instead, today’s successful marketers are leveraging personalized, data-driven, and omnichannel approaches that meet HCPs where they are.

Health and Personal Care Stores 52

Health and Personal Care Stores HIPAA Communication 52

Fierce Healthcare

MAY 20, 2025

With most eyes on Medicaid cuts in Congress, keep a close eye on ACA enrollment over the next six months, warn health policy experts.

98

98

Pharmacy Times

MAY 19, 2025

Panelists discuss how health care teams can ensure patients remain on optimal low-density lipoprotein cholesterol (LDL-C)lowering therapy by leveraging collaborative strategies, facilitating therapy intensification, and incorporating essential components into shared decision-making tools to personalize treatment plans.

65

65

Pharma Marketing Network

MAY 22, 2025

Selecting the right pharma marketing vendor in 2025 is no longer a simple matter of comparing capabilities or price points. The explosion of digital channels, AI-driven targeting, and compliance complexity has redefined what pharma marketers need from external partners. Whether youre launching a blockbuster brand like Tirzepatide or navigating market access challenges for a biosimilar, your vendors expertise can directly impact your outcomes.

Communication 52

Communication 52

Drug Topics

MAY 20, 2025

Researchers estimated the cost-effectiveness of PCV24 in the older adult population and compared it with currently accepted pneumococcal vaccine schedules in the US.

Vaccines 247

Vaccines 247

DiversifyRx

MAY 20, 2025

Break away from PBMs by offering services that patients love to grow non-PBM revenue. Lets face itPBM reimbursements are a nightmare. From unpredictable clawbacks to razor-thin margins, relying on PBMs alone is no way to run a profitable pharmacy. The good news? You dont have to. Non-PBM revenue is the golden ticket to sustainable growth, and the best way to tap into it is by offering services that patients actually value and are willing to pay for.

Health and Personal Care Stores 52

Health and Personal Care Stores Sterile Compounds Compounding Independent Pharmacies 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MAY 20, 2025

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead"

59

59

STAT

MAY 20, 2025

For decades, mainstream nutrition guidelines have recommended that Americans replace animal fats like butter or lard with polyunsaturated fats, especially seed oils such as soybean, corn, and sunflower oils. These oils are rich in omega-6 fatty acids and now make up a significant portion of the fat consumed in the standard American diet. But recently, the conversation has shifted.

126

126

Pharmaceutical Technology

MAY 20, 2025

Data presented at ATS 2025 showed that lung improvement in paediatric cystic fibrosis (CF) patients receiving ETI therapy is driven by regional mucus plug clearance.

52

52

Pharmacy Times

MAY 19, 2025

The Lumipulse G pTau217/-Amyloid 1-42 Plasma Ratio is the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

FDA 143

FDA 143

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

MAY 20, 2025

Patient-centric, large-scale real-world studies, which use data collected outside the system of controlled clinical trials, can and have already been delivered successfully. The tools, systems, and processes are available today, and modern technology has made it much easier to successfully run a real-world CNS study.

52

52

STAT

MAY 20, 2025

In a notable development, Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug costs to all residents, not just those employed by government agencies. The move was hailed by consumer advocates who hope the Prescription Drug Affordability Board, which is designed to function much like a state utility commission, will usher in era of lower medicine prices for everyone who lives in Maryland.

109

109

Pharma Marketing Network

MAY 18, 2025

Can a flashy website really move the needle for an oncology brand? Is social media too risky for pharma compliance? These questions reflect some of the biggest myths in digital marketing in pharma , an area that continues to evolve at warp speed yet remains tethered by legacy thinking. Many marketers in the pharmaceutical industry struggle to balance innovation with regulation, often falling into traps set by outdated beliefs.

FDA 52

FDA Communication 52

Pharmacy Times

MAY 19, 2025

A panelist discusses how physicians can support pharmacists in monitoring respiratory syncytial virus (RSV) vaccine adverse events (AEs), such as soreness, fatigue, and headache, while using clear, empathetic communication to educate patients about the temporary nature of these symptoms and the significant benefits of preventing severe RSV illness.

Communication 65

Communication Vaccines 65

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

MAY 20, 2025

In a briefing held by the Catholic Health Association, hospital leaders referred to the moral imperative they and Congress share to preserve the countrys safety net.

Hospitals 91

Hospitals 91

The Guardian - Pharmaceutical Industry

MAY 19, 2025

Drugmaker Regeneron Pharmaceuticals will buy the genetic testing firm through a bankruptcy auction The drugmaker Regeneron Pharmaceuticals will buy the genetic testing firm 23andMe Holding for $256m through a bankruptcy auction, the companies said on Monday. Regeneron said it will comply with 23andMes privacy policies and applicable laws with respect to the use of customer data and that it is ready to detail its intended use of the data to a court-appointed overseer.

84

84

pharmaphorum

MAY 19, 2025

DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal

80

80

Pharmacy Times

MAY 19, 2025

The vaccine, indicated with a restriction on use for those younger than 65 years and without comorbidities, was proven safe and effective in a series of large clinical trials, and marks the first protein-based vaccine to be approved in the United States.

Vaccines 73

Vaccines FDA 73

STAT

MAY 19, 2025

Imagine a world without lifesaving medicines, preventive care, or therapies — no insulin for diabetes, no vaccines for polio, and fewer (if any) options for treating cancer. What do these amazing medical achievements have in common? They all depended heavily on research using animals, the behind-the-scenes heroes of medical breakthroughs. Animal models play a starring role in medical discoveries because they help scientists understand how living organisms develop and function, and how the

Vaccines 143

Vaccines 143

Pharmafile

MAY 19, 2025

The US Food and Drug Administration (FDA) has approved Roches VENTANA MET (SP44) RxDx Assay as a diagnostic tool to identify non-squamous non-small cell lung cancer (NSQ-NSCLC) patients eligible for treatment with AbbVies targeted therapy Emrelis (telisotuzumab vedotin-tllv). The assessment detects an overexpression of the MET protein, a predictive biomarker associated with tumour progression and […] The post FDA approves diagnostic tool for MET-targeted lung cancer therapy appeared first

FDA 71

FDA 71

Pharmaceutical Technology

MAY 19, 2025

Novo Nordisk stated that replacing Jrgensen is "in the best interests of the company and its shareholders"

59

59

Pharmacy Times

MAY 19, 2025

A study reveals sasanlimab enhances event-free survival in high-risk bladder cancer patients, offering new hope against disease recurrence.

65

65

STAT

MAY 19, 2025

Molecular biologist Chiara Masnovo spent weeks filling out an application for a research fellowship earlier this year — taking it over the finish line as she was 38 weeks pregnant and starting a new job.  The chance of getting this fellowship was well worth the toil. The Hanna Gray fellowship, created by the Howard Hughes Medical institute, supports postdoctoral researchers from diverse backgrounds in their transition to heading their own labs.

119

119

Pharmafile

MAY 19, 2025

A breakthrough in lung therapy has been reported by German biotech company Viromed Medical whose cold plasma treatment has demonstrated 100% effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), a common cause of ventilator-associated pneumonia (VAP). In an in vitro study led by Hortense Slevogt at Hannover Medical School and the Helmholtz Centre for Infection Research, Germany, […] The post Cold plasma therapy shown to be 100% effective against pneumonia-causing bacter

Medical Schools 59

Medical Schools 59

pharmaphorum

MAY 19, 2025

Weve seen recent tariff policy changes creating an increasingly volatile environment for exporters and importers alike, particularly those in the medical device and IVD sectors.

59

59

Pharmacy Times

MAY 19, 2025

Panelists discuss how medical professionals consider PCSK9 inhibitors, bempedoic acid, and inclisiran in various clinical scenarios, their experiences with these newer therapies, the implications of the INCEPTION trial for treating patients with high-risk cardiovascular diseaseparticularly those who are statin-intolerantthe urgency of postcoronary event treatment, and emerging data on the broader impact of low-density lipoprotein cholesterol (LDL-C)lowering therapies on quality of life.

65

65

Pharmaceutical Technology

MAY 20, 2025

At ATS 2025, Sanofi and Regeneron announced the launch of a new Phase IIIb/IV clinical trial, AIM4, for asthma care.

52

52

PharmExec

MAY 19, 2025

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, explains why seamless communication and treatment continuity across primary care, cardiology, and rehabilitation are critical to improving outcomes and preventing care gaps for cardiovascular patients.

Communication 52

Communication 52

Pharmaceutical Commerce

MAY 19, 2025

The partnership is centered around cutting cold chain costs and emissions with smart packaging and carbon-neutral same-day delivery.

Packaging 52

Packaging 52